Net Revenues of $56.334 Billion, an Increase of 3.7 Percent on a Reported Basis and 4.6 Percent on an Operational Basis Delivers Fourth-Quarter Net Revenues of $15.102 Billion, an Increase of 5.6 ...
AbbVie forecast 2025 profit above estimates on Friday, as strong sales of its newer immunology drugs Skyrizi and Rinvoq make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback